ASCO GUIDELINES Bundle

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475462

Contents of this Issue

Navigation

Page 4 of 5

Table 1. Definition of Terms Term Description Genetic variant An alteration in the most common DNA nucleotide sequence. e term variant can be used to describe an alteration that may be benign, pathogenic, or of unknown significance. e term variant is increasingly being used in place of the term mutation. Germline variant A gene change in a reproductive cell (egg or sperm) that becomes incorporated into the DNA of every cell in the body of the offspring. A variant contained within the germline can be passed from parent to offspring and is, therefore, hereditary. Somatic variant An alteration in DNA that occurs aer conception and is not present within the germline. Somatic variants can occur in any of the cells of the body except the germ cells (sperm and egg ) and therefore are not passed on to children. Somatic variants can (but do not always) cause cancer or other diseases. Actionable genetic information e presence or absence of a genetic variant in a tumor or the germline that can be used to inform clinical management. (Adapted from Dancey et al. (Dancey JE, Bedard PL, Onetto N, et al.: e genetic basis for cancer treatment decisions. Cell 148 (3): 409-20, 2012.) Pathogenic Directly contributes to the development of disease. Additional evidence is not expected to alter the classification of this variant. [Note: Not all pathogenic variants are fully penetrant.] Likely pathogenic Very likely to contribute to the development of disease, but scientific evidence is currently insufficient to prove this conclusively. Uncertain significance ere is not enough information at this time to support a more definitive classification of this variant. Likely benign Not expected to have a major effect on disease, but the scientific evidence is currently insufficient to prove this conclusively. Benign Does not cause disease. Additional evidence is not expected to alter classification of this variant.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer